Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Radiation Oncology
•
Gynecologic Cancers
•
Genitourinary Cancers
Do you use Enterade in your patients receiving pelvic RT?
Related Questions
What are best practices for oncologists during the national platinum shortage?
Is there a benefit in proactively referring patients treated with pelvic radiation to see pelvic rehabilitation in the absence of any symptoms?
What dose and fields would you use for basosquamous carcinoma/basal cell carcinoma of the vulva s/p WLE but not fully excised due to adhesion to the rectum, with no further surgery offered?
How do you classify extensive LVSI in endometrial cancer?
In patient s/p definitive chemoRT for vulvar cancer with complete response, how do you manage a non-healing vulvar defect if biopsy is negative for residual disease?
Do you start prostate radiotherapy sooner in patients receiving neoadjuvant GnRH antagonists relugolix versus agonists such as leuprolide?
How do you assess treatment response after prostate XRT in the setting of low volume metastatic disease?
Do you use an SIB schema for salvage post-prostatectomy RT when treating the fossa in ~33-39 fractions and including the pelvic lymph nodes?
How do you dose or sequence therapy to overcome radioresistance from oligometastatic disease from RCC?
How does RTOG 0815 change your recommendation for ST-ADT for men getting XRT for favorable intermediate risk prostate ca?
